z-logo
open-access-imgOpen Access
Exvivo Experiments of Human Ovarian Cancer Ascites-Derived Exosomes Presented by Dendritic Cells Derived from Umbilical Cord Blood for Immunotherapy Treatment
Author(s) -
Qiling Li,
Ning Bu,
Yuecheng Yu,
Hua Wei,
Xiaoyan Xin
Publication year - 2008
Publication title -
clinical medicine oncology
Language(s) - English
Resource type - Journals
ISSN - 1177-9314
DOI - 10.4137/cmo.s776
Subject(s) - microvesicles , umbilical cord , cytotoxic t cell , medicine , immunology , antigen , dendritic cell , cancer research , immunotherapy , immune system , biology , in vitro , microrna , biochemistry , gene
Exosomes, a type of membrane vesicles, released from tumor cells have been shown to be capable of transferring tumor antigens to dendritic cells and activating specific cytotoxic T-lymphocytes. Recent work has demonstrated the presence of high numbers of exosomes in malignant effusions. Umbilical cord blood (UCB) is a rich source of hematopoietic stem cells and from which a significant number of dendritic cells can be produced. We hypothesized that the exosomes released from metastatic ovarian carcinoma were able to present tumor specific antigen to dendritic cells derived from unrelated umbilical cord blood, then could stimulate resting T cells to differentiate and induce effective cytotoxicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom